DOI QR코드

DOI QR Code

Prognostic Factors and Adjuvant Treatments for Surgically Treated Cancers of the Biliary Tract: A Multicentre Study of the Anatolian Society of Medical Oncology (ASMO)

  • 발행 : 2014.12.18

초록

Background: Biliary tract cancers are rare, and surgical resection is the standard treatment at early stages. However, reports on the benefits of adjuvant treatment following surgical resection are conflicting. This study aimed to evaluate the factors affecting survival and adjuvant treatments in patients with surgically treated biliary tract cancers. Materials and Methods: Patient clinical features, adjuvant treatments, and efficacy and prognostic factor data were evaluated. Survival analyses were performed using SPSS 15.0. Results: The median overall survival was 30.7 months (95% confidence interval [CI], 18.4-42.9 months). Median survival was 19 months (95% CI, 6-33) for patients treated with fluorouracil based chemotherapy and 53 months (95% CI, 33.2-78.8) with gemcitabine based chemotherapy(p=0.033). On univariate analysis, poor prognostic factors for survival were galbladder localization, perineural invasion, hepatic invasion, a lack of adjuvant chemoradiotherapy treatment, and a lack of lymph node dissection. On multivariate analysis, perineural invasion was a poor prognostic factor (p=0.008). Conclusions: Biliary tract cancers generally have poor prognoses. The main factors affecting survival are tumour localization, perineural invasion, hepatic invasion, adjuvant chemoradiotherapy, and lymph node dissection. Gemcitabine-based adjuvant chemotherapy is more effective than 5-fluorouracil-based chemotherapy.

키워드

참고문헌

  1. Berardi R, Mocchegiani F, Pierantoni C, et al (2013). Resected biliary tract cancers: a novel clinical-pathological score correlates with global outcome. Dig Liver Dis, 45, 70-4. https://doi.org/10.1016/j.dld.2012.08.012
  2. Bhudhisawasdi V, Talabnin C, Pugkhem A, et al(2012). Evaluation of postoperative adjuvant chemotherapy for intrahepatic cholangiocarcinoma patients undergoing R1 and R2 resections. Asian Pac J Cancer Prev, 13, 169-74. https://doi.org/10.7314/APJCP.2012.13.1.169
  3. Bonet Beltran M, Roth AD, Mentha G, et al (2011). Adjuvant radio-chemotherapy for extrahepatic biliary tract cancers. BMC Cancer, 11, 267. https://doi.org/10.1186/1471-2407-11-267
  4. Choi SB, Kim KS, Choi JY, et al(2009). The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol, 16, 3048-56. https://doi.org/10.1245/s10434-009-0631-1
  5. Choi SB, Kim WB, Song TJ, et al(2011). Surgical outcomes and prognostic factors for ampulla of Vater cancer. Scand J Surg, 100, 92-8.
  6. Eckel F, Schmid RM(2007). Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Br J Cancer, 96, 896-902. https://doi.org/10.1038/sj.bjc.6603648
  7. Falconi M, Crippa S, Dominguez I, et al(2008). Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma. Ann Surg Oncol, 15, 3178-86. https://doi.org/10.1245/s10434-008-0099-4
  8. Fisher SB, Patel SH, Kooby DA, et al(2012). Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multiinstitution analysis. HPB, 14, 514-22. https://doi.org/10.1111/j.1477-2574.2012.00489.x
  9. Horgan AM, Amir E, Walter T, et al(2012). Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol, 30, 1934-40. https://doi.org/10.1200/JCO.2011.40.5381
  10. Kalayarasan R, Javed A, Sakhuja P, et al(2013). Squamous variant of gallbladder cancer: is it different from adenocarcinoma? Am J Surg, 206, 380-5. https://doi.org/10.1016/j.amjsurg.2012.12.012
  11. Kamsa-ard S, Laopaiboon M, Luvira V, et al(2013). Association between praziquantel and cholangiocarcinoma in patients infected with Opisthorchis viverrini: a systematic review and meta analysis. Asian Pac J Cancer Prev, 14, 7011-6. https://doi.org/10.7314/APJCP.2013.14.11.7011
  12. Kawamata H, Yamashita K, Nakamura K, et al(2013). Perineural invasion and preoperative serum CA19-9 as predictors of survival in biliary tract cancer. Anticancer Res, 33, 583-94.
  13. Kim K, Chie EK, Jang JY, et al(2012). Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience. Am J Clin Oncol, 35,136-40. https://doi.org/10.1097/COC.0b013e318209aa29
  14. Klempnauer J, Ridder GJ, Von Wasielewski R, et al(1997). Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol, 15, 947-54.
  15. Murakami Y, Uemura K, Sudo T, et al (2011). Prognostic factors of patients with advanced gallbladder carcinoma following aggressive surgical resection. J Gastrointest Surg, 15, 1007-16. https://doi.org/10.1007/s11605-011-1479-9
  16. Murakami Y, Uemura K, Sudo T, et al (2013). Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies. J Gastrointest Surg, 17, 1429-39. https://doi.org/10.1007/s11605-013-2251-0
  17. Nanashima A, Tobinaga S, Abo T, et al(2012). Evaluation of surgical resection for gallbladder carcinoma at a Japanese cancer institute. Hepatogastroenterology, 59, 1717-21.
  18. Neoptolemos JP, Moore MJ, Cox TF, et al (2012). Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA, 308, 147-56. https://doi.org/10.1001/jama.2012.7352
  19. Palta M, Patel P, Broadwater G, et al (2012). Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy. Ann Surg Oncol, 19, 1535-40. https://doi.org/10.1245/s10434-011-2117-1
  20. Pattanathien P, Khuntikeo N, Promthet S, et al (2013). Survival rate of extrahepatic cholangiocarcinoma patients after surgical treatment in Thailand. Asian Pac J Cancer Prev, 14, 321-4. https://doi.org/10.7314/APJCP.2013.14.1.321
  21. Qu K, Liu SN, Chang HL, et al (2012). Gallbladder cancer: a subtype of biliary tract cancer which is a current challenge in China. Asian Pac J Cancer Prev, 13, 1317-20. https://doi.org/10.7314/APJCP.2012.13.4.1317
  22. Rea DJ, Munoz-Juarez M, Farnell MB, et al (2004). Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg, 139, 514-23. https://doi.org/10.1001/archsurg.139.5.514
  23. Sierzega M, Nowak K, Kulig J, et al (2009). Lymph node involvement in ampullary cancer: the importance of the number, ratio, and location of metastatic nodes. J Surg Oncol, 100, 19-24. https://doi.org/10.1002/jso.21283
  24. Sriputtha S, Khuntikeo N, Promthet S, et al (2013). Survival rate of intrahepatic cholangiocarcinoma patients after surgical treatment in Thailand. Asian Pac J Cancer Prev, 14, 1107-10. https://doi.org/10.7314/APJCP.2013.14.2.1107
  25. Takada T, Amano H, Yasuda H, et al (2002). Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer, 95, 1685-95. https://doi.org/10.1002/cncr.10831
  26. Tamandl D, Kaczirek K, Gruenberger B, et al (2009). Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. Br J Surg, 96, 919-25. https://doi.org/10.1002/bjs.6654
  27. Tan JW, Hu BS, Chu YJ, et al (2013). One-stage resection for Bismuth type IV hilar cholangiocarcinoma with high hilar resection and parenchyma-preserving strategies: a cohort study. World J Surg, 37, 614-21. https://doi.org/10.1007/s00268-012-1878-4
  28. Tan X, Xiao K, Liu W, et al (2013). Prognostic factors of distal cholangiocarcinoma after curative surgery: a series of 84 cases. Hepatogastroenterology, 60, 1892-5.
  29. Wang SJ, Lemieux A, Kalpathy-Cramer J, et al (2011). Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol, 29, 4627-32. https://doi.org/10.1200/JCO.2010.33.8020
  30. Woradet S, Promthet S, Songserm N, et al (2013). Factors affecting survival time of cholangiocarcinoma patients: a prospective study in Northeast Thailand. Asian Pac J Cancer Prev, 14, 1623-7. https://doi.org/10.7314/APJCP.2013.14.3.1623

피인용 문헌

  1. Epidemiologic Data, Tumor Size, Histologic Tumor Type and Grade, Pathologic Staging and Follow Up in Cancers of the Ampullary Region and Head of Pancreas in 311 Whipple Resection Specimens of Pakistani Patients vol.16, pp.17, 2015, https://doi.org/10.7314/APJCP.2015.16.17.7541